Recall archive / FDA company announcement

TING®: 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid — FDA announcement Feb 2, 2024

Published notice; closure not supplied

A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.

Source date Feb 2, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product: 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid
Reason: Presence of benzene
Classification: Not supplied
Recalling firm: Insight Pharmaceuticals
Quantity: Not supplied
Agency-reported status: Company recall announcement
Source record identifier: 52a6d7215a8f2610

Open the official record

Lot and product identifiers

Label field	Details supplied by the agency
Lot, code or applicability	TARRYTOWN, N.Y.--(GLOBE NEWSWIRE)-February 1, 2024—Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling two lots of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid to the consumer level. A recent review by our manufacturer and their third-party lab found that samples from two lots of the product contained elevated levels of benzene. While benzene is not an ingredient in any Ting® Antifungal Spray products, the review showed that unexpected levels of benzene came from the propellant that sprays the product out of the can. Importantly, no other lots of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid (either before or after these batch codes) and no other Ting® Antifungal Spray Liquid products are in the scope of this recall and may continue to be used by consumers safely and as intended.; TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid is packaged in blue and white aerosol cans with Lot codes located on the bottom of the can.; Insight has notified retailers via overnight mail to remove any remaining recalled product from shelves and follow the instructions provided in the Drug Recall Notification. The company will also offer reimbursement for consumers who have purchased TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid marked with one of the lot codes in the table above. Consumers can contact Insight Pharmaceuticals via e-mail at [email protected], through its website at https://www.prestigebrands.com/contact, or by phone at (800) 344-7239 on Monday – Friday 8:30-5:30 eastern time to receive a full refund by providing a picture of the bottom of the can of the TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid with the affected lot number. Consumers that have product which is being recalled should stop using the product immediately and appropriately discard after taking the picture.; Product \| NDC \| Lot Number \| Expiration Date \| Package Size; TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid \| 63736- 819-05 \| 0H50545 \| 07/24 \| 4.5 oz/128 g; TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid \| 63736- 819-05 \| 1G50645 \| 06/25 \| 4.5 oz/128 g

Label field

Details supplied by the agency

Lot, code or applicability

TARRYTOWN, N.Y.--(GLOBE NEWSWIRE)-February 1, 2024—Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling two lots of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid to the consumer level. A recent review by our manufacturer and their third-party lab found that samples from two lots of the product contained elevated levels of benzene. While benzene is not an ingredient in any Ting® Antifungal Spray products, the review showed that unexpected levels of benzene came from the propellant that sprays the product out of the can. Importantly, no other lots of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid (either before or after these batch codes) and no other Ting® Antifungal Spray Liquid products are in the scope of this recall and may continue to be used by consumers safely and as intended.; TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid is packaged in blue and white aerosol cans with Lot codes located on the bottom of the can.; Insight has notified retailers via overnight mail to remove any remaining recalled product from shelves and follow the instructions provided in the Drug Recall Notification. The company will also offer reimbursement for consumers who have purchased TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid marked with one of the lot codes in the table above. Consumers can contact Insight Pharmaceuticals via e-mail at [email protected], through its website at https://www.prestigebrands.com/contact, or by phone at (800) 344-7239 on Monday – Friday 8:30-5:30 eastern time to receive a full refund by providing a picture of the bottom of the can of the TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid with the affected lot number. Consumers that have product which is being recalled should stop using the product immediately and appropriately discard after taking the picture.; Product | NDC | Lot Number | Expiration Date | Package Size; TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid | 63736- 819-05 | 0H50545 | 07/24 | 4.5 oz/128 g; TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid | 63736- 819-05 | 1G50645 | 06/25 | 4.5 oz/128 g

Match all identifying details in the current notice. A brand name alone is not enough.

Product tables from the announcement

These identifying details come from the company announcement posted by FDA. Check the current notice for revisions.

FDA company announcement, table 1
Product	NDC	Lot Number	Expiration Date	Package Size
TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid	63736- 819-05	0H50545	07/24	4.5 oz/128 g
TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid	63736- 819-05	1G50645	06/25	4.5 oz/128 g

Announcement retrieved Oct 1, 2026. Official announcement.

Distribution

Not supplied

No US distribution state could be established from this record. Check the official notice.

Dates in the source

Fda listing date: Feb 2, 2024
Company announcement date: Feb 1, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.